Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Cincinnati
About this trial
The purpose this research is to compare two different standards of care for pain management and two different standards of care for local numbing medicine for breast cancer patients who will have a total mastectomy.
Eligibility criteria
Qualifiers
Patients who are 18 years of age or older
Patients undergoing mastectomy with or without axillary surgery, with or without reconstruction surgery at UCMC for breast cancer or high-risk of breast cancer. Patients with high-risk of breast cancer are those who have atypical/precancerous breast lesion(s), genetic mutation with increased risk of cancer (e.g., BRCA1, BRCA2 etc..) and/or a strong family history of breast cancer in the opinion of the investigator.
Disqualifiers
Patients undergoing only a partial mastectomy or tissue-based reconstruction.
Non-English speaking.
Patients who are pregnant.
Patients with an allergy to local anesthetics
Trial design
Treatments tested in this trial
- Bupivacain
- Exparel
- Intraoperative Pecs II block (IOB) & superior AT (EX or BP)
- Preoperative Pecs II block (POB) & superior AT (EX or BP)
Treatment groups
100 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov